nifedipine has been researched along with thromboxane a2 in 49 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 17 (34.69) | 18.7374 |
| 1990's | 26 (53.06) | 18.2507 |
| 2000's | 5 (10.20) | 29.6817 |
| 2010's | 1 (2.04) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alivanis, P; Grekas, D; Kalekou, H; Karamouzis, M; Papayianni, K; Tourkantonis, A | 1 |
| Akopov, SE; Gabrielian, ES; Grigorian, GS; Kazarian, AV; Mkhitarian, GS; Tunian, IuS | 1 |
| Abbate, R; Boddi, M; Coppo, M; Gensini, GF; Neri Serneri, GG; Prisco, D; Rostagno, C | 1 |
| Ishii, A; Karasawa, A; Kawakage, M; Kubo, K; Miki, I; Shirakura, S; Takeda, M | 1 |
| Fujiwara, M; Kurahashi, K; Shimaji, H; Shirahase, H; Usui, H | 1 |
| Akimoto, Y; Fujiwara, M; Kurahashi, K; Usui, H | 1 |
| Akimoto, Y; Fujiwara, M; Kurahashi, K; Shibata, S; Shirahase, H; Suzuki, A; Usui, H | 1 |
| Abbate, R; Boddi, M; Costanzo, G; Paniccia, R; Poggesi, L; Prisco, D; Rostagno, C | 1 |
| Johnson, G; Keagy, BA; Ramadan, FM; Upchurch, GR | 1 |
| Francis, GS; Johnson, GJ; Leis, LA | 2 |
| Fujiwara, M; Kurahashi, K; Manabe, K; Shirahase, H; Usui, H | 1 |
| Kito, M; Matsuura, T; Moriyama, T; Narita, H; Takamura, H; Tanaka, K | 1 |
| Cooper, RC; du Toit, HJ; King, JB; Macfarlane, CM; Taljaard, JJ | 1 |
| Betteridge, DJ; Dandona, P; Hendra, TJ; Jeremy, JY; Oughton, J; Smith, CC; Yudkin, JS | 1 |
| Calder, AA; Forbes, CD; Greer, IA; McLaren, M; Walker, JJ | 1 |
| Hall, ED; Wolf, DL | 1 |
| Barradas, MA; Dandona, P; Grace, AA; Jeremy, JY; Mikhailidis, DP; Moorhead, JF; Sweny, P | 1 |
| Fujiwara, T; Itoh, T; Kuriyama, H | 1 |
| Itoh, T; Kanmura, Y; Kuriyama, H | 1 |
| Iwanov, V; Moulds, RF; Young, MS | 1 |
| Barradas, MA; Dandona, P; Jeremy, JY; Mikhailidis, DP | 1 |
| Lefer, AM; Nicolaou, KC; Smith, EF | 1 |
| Honn, KV; Onoda, JM; Sloane, BF | 1 |
| Kubo, K; Nakamizo, N; Shuto, K; Yamada, K | 1 |
| Imai, S; Katano, Y | 1 |
| Perzborn, E; Towart, R | 1 |
| Crowley, MR; Fineman, JR; Soifer, SJ | 1 |
| Antunes, E; De Nucci, G; Muscará, MN; Ribeiro, MO; Zatz, R | 1 |
| Kalsner, S | 1 |
| Cocks, TM; Stork, AP | 1 |
| Gibson, A; McFadzean, I; Tucker, JF; Wayman, C | 1 |
| Kimblad, PO; Steen, S | 1 |
| Boura, AL; Di Grande, A; Malatino, LS; Read, MA; Walters, WA | 1 |
| Angus, JA; Cocks, TM; Kemp, BK; Pruneau, D | 1 |
| Walker, BR | 1 |
| Manninen, A | 1 |
| Garland, CJ; Plane, F | 1 |
| Jino, H; Kurahashi, K; Nakata, Y; Shimizu, Y; Temma, S; Usui, H | 1 |
| Angus, JA; Fujiwara, T | 1 |
| Epstein, M; Hayashi, K; Loutzenhiser, R | 1 |
| Fukuta, Y; Higashino, R; Inoue, N; Jin, H; Kurimoto, T; Sato, R; Tamaki, H | 1 |
| Aldasoro, M; Lluch, S; Medina, P; Noguera, I; Segarra, G; Vila, JM | 1 |
| Kurumatani, H; Matsushita, T; Tamura, M | 1 |
| Ballester, RM; Lluch, S; Martínez-León, JB; Medina, P; Otero, E; Segarra, G; Vila, JM | 1 |
| Cogolludo, A; Lodi, F; Moreno, L; Perez-Vizcaino, F; Tamargo, J | 1 |
| Arshad, M; Floyd, BC; Gupte, SA; Marks, B; Sarabu, MR; Vijay, V; Wolin, MS | 1 |
| Epstein, M; Loutzenhiser, R | 1 |
| Li, M; Qiu, SQ; Yao, J; Zhang, M; Zheng, XY; Zhu, JM; Zhu, ZX | 1 |
4 trial(s) available for nifedipine and thromboxane a2
| Article | Year |
|---|---|
Effects of calcium channel blockers on platelet aggregation and thromboxane A2 formation: an in vivo double blind randomized study.
Topics: Adult; Blood Platelets; Calcium Channel Blockers; Diltiazem; Double-Blind Method; Female; Humans; Male; Middle Aged; Nifedipine; Platelet Aggregation; Thromboxane A2; Verapamil | 1990 |
Aetiology of pulmonary dysfunction in total hip replacement operations. The influence of nifedipine on the factors involved.
Topics: Aged; Aged, 80 and over; beta-Thromboglobulin; Clinical Trials as Topic; Complement C5; Double-Blind Method; Epoprostenol; Female; Hip Joint; Hip Prosthesis; Humans; Intraoperative Period; Lung Diseases; Male; Nifedipine; Postoperative Complications; Postoperative Period; Random Allocation; Thromboxane A2 | 1987 |
Cyclosporine A enhances platelet aggregation.
Topics: Adult; Azathioprine; Calcium; Cyclosporins; Dose-Response Relationship, Drug; Drug Synergism; Female; Heparin; Humans; In Vitro Techniques; Kidney Transplantation; Male; Middle Aged; Nifedipine; Platelet Aggregation; Thromboxane A2 | 1987 |
Nifedipine reduces thromboxane A2 production by platelets without changing aggregation in hypertensive pregnancy.
Topics: Adult; Antihypertensive Agents; Blood Platelets; Blood Pressure; Female; Humans; Hypertension; In Vitro Techniques; Male; Nifedipine; Platelet Aggregation; Platelet Count; Pregnancy; Pregnancy Complications, Cardiovascular; Thromboxane A2 | 1996 |
45 other study(ies) available for nifedipine and thromboxane a2
| Article | Year |
|---|---|
Acute cyclosporin A renal dysfunction in dogs reversed by calcium antagonists and antiplatelet agents.
Topics: Animals; Calcium Channel Blockers; Cyclosporine; Dogs; Drug Interactions; Kidney; Kidney Tubular Necrosis, Acute; Nifedipine; Piracetam; Platelet Aggregation Inhibitors; Thromboxane A2; Thromboxane B2; Time Factors; Vasoconstriction | 1992 |
[Status of the prostacyclin-thromboxane balance in patients with cerebrovascular disorders and the effect of the treatment with nifedipine].
Topics: 6-Ketoprostaglandin F1 alpha; Acute Disease; Aged; Cerebral Infarction; Cerebrovascular Circulation; Epoprostenol; Humans; Intracranial Arteriosclerosis; Middle Aged; Nifedipine; Thromboxane A2 | 1991 |
In vitro effects of two novel calcium antagonists (nitrendipine and nisoldipine) on intraplatelet calcium redistribution, platelet aggregation and thromboxane A2 formation. Comparison with diltiazem, nifedipine and verapamil.
Topics: Adult; Blood Platelets; Calcium; Calcium Channel Blockers; Diltiazem; Female; Humans; In Vitro Techniques; Male; Nifedipine; Nisoldipine; Nitrendipine; Platelet Aggregation; Thromboxane A2; Thromboxane B2; Verapamil | 1991 |
Beneficial effect of the novel thromboxane A2 receptor antagonist sodium (E)-11-[2-(5,6-dimethyl-1-benzimidazolyl)ethylidene]-6,11- dihydrodibenz[b,e]oxepine-2-carboxylate monohydrate on collagen-induced coronary ischemia in guinea-pigs.
Topics: Animals; Arrhythmias, Cardiac; Benzimidazoles; Benzoxepins; Collagen; Coronary Disease; Cyclooxygenase Inhibitors; Electrocardiography; Guinea Pigs; Heart Arrest; Male; Nifedipine; Phenylacetates; Propranolol; Sulfonamides; Thromboxane A2; Thromboxane B2; Thromboxanes; Ticlopidine | 1991 |
Endothelium-independent and endothelium-dependent contractions mediated by P2X- and P2Y-purinoceptors in canine basilar arteries.
Topics: Adenosine Triphosphate; Animals; Aspirin; Basilar Artery; Calcium; Dogs; Endothelium, Vascular; Female; Male; Methacrylates; Nifedipine; Receptors, Purinergic; Thromboxane A2; Vasoconstriction | 1991 |
Vasoinhibitory effect of NP-252, a new dihydropyridine derivative, in canine cerebral artery.
Topics: Animals; Calcium; Cerebral Arteries; Coronary Vessels; Dihydropyridines; Dogs; Dose-Response Relationship, Drug; Drug Resistance; Female; Male; Muscle Contraction; Muscle, Smooth, Vascular; Nifedipine; Potassium Chloride; Thromboxane A2 | 1991 |
Effects of nitroglycerin on stable thromboxane A2 analogue-induced, nifedipine-resistant contraction in canine basilar artery.
Topics: Animals; Basilar Artery; Calcium; Coronary Vessels; Dogs; Muscle Contraction; Nifedipine; Nitroglycerin; Thromboxane A2 | 1990 |
Endothelial cell thromboxane production and its inhibition by a calcium-channel blocker.
Topics: Animals; Arachidonic Acids; Cell Count; Cell Survival; Cells, Cultured; Culture Media; Endothelium, Vascular; Nifedipine; Rabbits; Thromboxane A2 | 1990 |
Adenosine potentiates the inhibitory effects of calcium channel antagonists on human platelet aggregation induced by thromboxane A2 or U46619.
Topics: Adenosine; Alprostadil; Calcium Channel Blockers; Diltiazem; Drug Synergism; Epinephrine; Humans; In Vitro Techniques; Nifedipine; Platelet Aggregation Inhibitors; Prostaglandin Endoperoxides, Synthetic; Thromboxane A2; Verapamil | 1990 |
An endothelium-dependent contraction induced by A-23187, a Ca++ ionophore in canine basilar artery.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Aspirin; Basilar Artery; Calcimycin; Dogs; Endothelium, Vascular; Female; Male; Methacrylates; Nifedipine; Quinacrine; Thromboxane A2; Vasoconstriction | 1988 |
Dihydropyridine-sensitive and insensitive Ca2+ channels in human platelets.
Topics: Blood Platelets; Calcium Channels; Collagen; Diltiazem; Humans; In Vitro Techniques; Nifedipine; Thromboxane A2 | 1988 |
Ex vivo platelet studies following oral nisoldipine in normotensive insulin-dependent diabetics and non-diabetic controls.
Topics: Adenosine Diphosphate; beta-Thromboglobulin; Blood Platelets; Catecholamines; Collagen; Diabetes Mellitus, Type 1; Epinephrine; Humans; In Vitro Techniques; Nifedipine; Nisoldipine; Physical Exertion; Platelet Aggregation; Platelet Factor 4; Reference Values; Thromboxane A2 | 1988 |
Disparate effects of the calcium-channel blockers, nifedipine and verapamil, on alpha 2-adrenergic receptors and thromboxane A2-induced aggregation of human platelets.
Topics: Adenosine Diphosphate; Adult; Arachidonic Acid; Arachidonic Acids; Blood Platelets; Chromatography, Gel; Collagen; Cyclic AMP; Drug Synergism; Epinephrine; Humans; Nifedipine; Platelet Aggregation; Prostaglandin Endoperoxides, Synthetic; Receptors, Adrenergic, alpha; Thromboxane A2; Tritium; Verapamil; Yohimbine | 1986 |
Inhibition of whole blood platelet aggregation by nicardipine, and synergism with prostacyclin in-vitro.
Topics: Adenosine Diphosphate; Antihypertensive Agents; Arachidonic Acid; Arachidonic Acids; Collagen; Drug Synergism; Epoprostenol; Female; Humans; Kinetics; Male; Nicardipine; Nifedipine; Platelet Aggregation; Reference Values; Thromboxane A2; Thromboxane B2 | 1986 |
A pharmacological analysis of the pathophysiological mechanisms of posttraumatic spinal cord ischemia.
Topics: Animals; Benzofurans; Calcium Channel Blockers; Cats; Cyclooxygenase Inhibitors; Diltiazem; Dinoprost; Epoprostenol; Female; Ibuprofen; Ischemia; Male; Meclofenamic Acid; Nifedipine; Prostaglandin Antagonists; Prostaglandins F; Spinal Cord; Thromboxane A2; Verapamil; Vitamin E | 1986 |
Regional differences in the mechanical properties of rabbit airway smooth muscle.
Topics: Acetylcholine; Animals; Asthma; Bronchi; Histamine; In Vitro Techniques; Indomethacin; Male; Muscle Contraction; Muscle, Smooth; Nifedipine; Potassium; Prostaglandins F; Rabbits; Thromboxane A2; Trachea | 1988 |
Mechanisms of vasoconstriction induced by 9,11-epithio-11,12-methano-thromboxane A2 in the rabbit coronary artery.
Topics: Animals; Arteries; Atropine; Biomechanical Phenomena; Calcium; Coronary Vessels; Endothelium; In Vitro Techniques; Male; Nifedipine; Prazosin; Rabbits; Thromboxane A2; Vasoconstriction | 1987 |
Interaction between platelet-released serotonin and thromboxane A2 on human digital arteries.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Arteries; Blood Platelets; Calcium; Drug Synergism; Humans; In Vitro Techniques; Nifedipine; Prostaglandin Endoperoxides, Synthetic; Serotonin; Thromboxane A2; Verapamil | 1986 |
An investigation into the effects of nifedipine and nimodipine on platelet function and vascular prostacyclin synthesis.
Topics: Animals; Arachidonic Acid; Arachidonic Acids; Arteries; Blood Platelets; Calcium; Epoprostenol; In Vitro Techniques; Nifedipine; Nimodipine; Platelet Aggregation; Rats; Rats, Inbred Strains; Thromboxane A2 | 1985 |
Mechanism of coronary vasoconstriction induced by carbocyclic thromboxane A2.
Topics: Animals; Calcium; Cats; Coronary Vessels; Female; Male; Nifedipine; Receptors, Adrenergic, alpha; Receptors, Angiotensin; Thromboxane A2; Thromboxanes; Vasoconstriction; Verapamil | 1981 |
Antithrombogenic effects of calcium channel blockers: synergism with prostacyclin and thromboxane synthase inhibitors.
Topics: Adenosine Diphosphate; Benzofurans; Blood Platelets; Calcium Channel Blockers; Diltiazem; Drug Synergism; Epoprostenol; Humans; Nicotinic Acids; Nifedipine; Nimodipine; Oxidoreductases; Platelet Aggregation; Thrombin; Thromboxane A2; Thromboxane-A Synthase; Verapamil | 1984 |
Inhibition of thromboxane A2-induced vasocontraction by KF4939, a new anti-platelet agent, in rabbit mesenteric and dog coronary arteries.
Topics: Angiotensin II; Animals; Benzamides; Blood Platelets; Calcium; Coronary Vessels; Dogs; Histamine; In Vitro Techniques; Male; Mesenteric Arteries; Nifedipine; Norepinephrine; Potassium Chloride; Rabbits; Serotonin; Thromboxane A2; Thromboxanes; Vasoconstriction | 1984 |
The effects of dipyridamole on TXA2 formation by horse platelet microsomes.
Topics: Animals; Blood Platelets; Dipyridamole; Horses; Imidazoles; In Vitro Techniques; Microsomes; Muscle Contraction; Muscle, Smooth, Vascular; Nifedipine; Thromboxane A2; Thromboxanes; Vasodilator Agents | 1983 |
Relaxation of carbocyclic thromboxane A2-induced contractions of isolated coronary arteries by nifedipine.
Topics: Animals; Cats; Coronary Vessels; Dimethyl Sulfoxide; In Vitro Techniques; Male; Muscle Contraction; Muscle, Smooth, Vascular; Nifedipine; Papaverine; Potassium Chloride; Pyridines; Thromboxane A2; Thromboxanes | 1982 |
HA1004, an intracellular calcium antagonist, selectively attenuates pulmonary hypertension in newborn lambs.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Animals, Newborn; Calcium Channel Blockers; Hemodynamics; Hypertension, Pulmonary; Hypoxia; Infusions, Intravenous; Isoquinolines; Muscle Relaxation; Nifedipine; Prostaglandin Endoperoxides, Synthetic; Protein Kinase Inhibitors; Pulmonary Alveoli; Regression Analysis; Sheep; Sulfonamides; Thromboxane A2 | 1994 |
Nifedipine prevents renal injury in rats with chronic nitric oxide inhibition.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Arginine; Blood Pressure; Calcium Channel Blockers; Hemodynamics; Hypertension; In Vitro Techniques; Kidney; Kidney Glomerulus; Male; Nephritis, Interstitial; NG-Nitroarginine Methyl Ester; Nifedipine; Nitric Oxide; Norepinephrine; Prostaglandin Endoperoxides, Synthetic; Rats; Rats, Wistar; Thromboxane A2; Time Factors; Vasoconstrictor Agents | 1995 |
Non-neurogenic contractions in isolated coronary arteries by brief electrical pulses.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Calcium; Cattle; Coronary Vessels; Diltiazem; Electric Stimulation; In Vitro Techniques; Insecticides; Muscle Contraction; Muscle, Smooth, Vascular; Nifedipine; Prostaglandin Endoperoxides, Synthetic; Pyrethrins; Ryanodine; Thromboxane A2; Vasoconstrictor Agents | 1994 |
Pharmacological reactivity of human epicardial coronary arteries: phasic and tonic responses to vasoconstrictor agents differentiated by nifedipine.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Adolescent; Adult; Calcium Channels; Coronary Vessels; Endothelins; Female; Humans; In Vitro Techniques; Male; Middle Aged; Muscle Contraction; Muscle, Smooth, Vascular; Nifedipine; Prostaglandin Endoperoxides, Synthetic; Serotonin; Thromboxane A2; Vasoconstrictor Agents | 1994 |
Variable potency of nitrergic-nitrovasodilator relaxations of the mouse anococcygeus against different forms of induced tone.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Anti-Arrhythmia Agents; Calcium Channel Blockers; Calcium-Transporting ATPases; Carbachol; Cyclic GMP; Imidazoles; In Vitro Techniques; Indoles; Male; Mice; Muscle Contraction; Muscle Relaxation; Muscle Tonus; Muscle, Smooth; Nifedipine; Nitric Oxide; Nitroprusside; Platelet Aggregation Inhibitors; Potassium; Prostaglandin Endoperoxides, Synthetic; Thromboxane A2; Vasoconstrictor Agents; Vasodilation | 1994 |
Eliminating the strong pulmonary vasoconstriction caused by Euro-Collins solution.
Topics: Alprostadil; Animals; Constriction, Pathologic; Drug Combinations; Drug Interactions; Endothelium, Vascular; Epoprostenol; Hypertonic Solutions; Models, Biological; Nifedipine; Papaverine; Phenylacetates; Pulmonary Artery; Severity of Illness Index; Sulfonamides; Swine; Thromboxane A2; Thromboxanes; Vasoconstriction; Vasodilator Agents | 1994 |
Modulation by adenosine of thromboxane A2 receptor-mediated constriction in the human umbilical artery.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Adenosine; Adolescent; Adult; Biphenyl Compounds; Calcium Channels; Drug Interactions; Female; Heptanoic Acids; Humans; Muscle, Smooth, Vascular; Nifedipine; Prostaglandin Endoperoxides, Synthetic; Receptors, Thromboxane; Thromboxane A2; Umbilical Arteries; Vasoconstriction; Vasoconstrictor Agents | 1994 |
Comparison of contractile responses to 5-hydroxytryptamine and sumatriptan in human isolated coronary artery: synergy with the thromboxane A2-receptor agonist, U46619.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Coronary Vessels; Drug Synergism; Ergonovine; Humans; In Vitro Techniques; Isometric Contraction; Methysergide; Muscle Contraction; Muscle, Smooth, Vascular; Nifedipine; Norepinephrine; Prostaglandin Endoperoxides, Synthetic; Receptors, Thromboxane; Serotonin; Serotonin Receptor Agonists; Sumatriptan; Thromboxane A2; Vasoconstrictor Agents | 1993 |
Evidence for uneven distribution of L-type calcium channels in rat pulmonary circulation.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Blood Vessels; Calcium Channel Blockers; Calcium Channels; In Vitro Techniques; Male; Nifedipine; Potassium; Prostaglandin Endoperoxides, Synthetic; Pulmonary Circulation; Rats; Rats, Sprague-Dawley; Thromboxane A2; Tissue Distribution; Vasoconstriction; Vasoconstrictor Agents | 1995 |
Influence of contractile agonists on the mechanism of endothelium-dependent relaxation in rat isolated mesenteric artery.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Acetylcholine; Animals; Drug Interactions; Endothelium, Vascular; Enzyme Inhibitors; In Vitro Techniques; Male; Membrane Potentials; Mesenteric Artery, Superior; Muscle Contraction; Muscle Relaxation; Muscle, Smooth, Vascular; NG-Nitroarginine Methyl Ester; Nifedipine; Nitric Oxide Synthase; Nitroarginine; Norepinephrine; Prostaglandin Endoperoxides, Synthetic; Rats; Rats, Wistar; Stimulation, Chemical; Thromboxane A2; Vasoconstrictor Agents; Vasodilator Agents | 1996 |
Pharmacological nature of TP receptor mediated contraction in human intrapulmonary artery.
Topics: Adult; Aged; Calcium; Colforsin; Female; Humans; In Vitro Techniques; Male; Middle Aged; Muscle Contraction; Nifedipine; Nitroglycerin; Pulmonary Artery; Receptors, Prostaglandin; Receptors, Thromboxane A2, Prostaglandin H2; Thromboxane A2; Type C Phospholipases | 1996 |
Analysis of relaxation and repolarization mechanisms of nicorandil in rat mesenteric artery.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Benzopyrans; Calcium Channel Blockers; Cromakalim; Electrophysiology; Glyburide; Hypoglycemic Agents; In Vitro Techniques; Male; Membrane Potentials; Mesenteric Arteries; Methylene Blue; Muscle Relaxation; Muscle, Smooth, Vascular; Niacinamide; Nicorandil; Nifedipine; Potassium Channels; Prostaglandin Endoperoxides, Synthetic; Pyrroles; Rats; Rats, Sprague-Dawley; Thromboxane A2; Vasoconstrictor Agents; Vasodilator Agents | 1996 |
Direct evidence that thromboxane mimetic U44069 preferentially constricts the afferent arteriole.
Topics: Animals; Arterioles; Bridged Bicyclo Compounds, Heterocyclic; Calcium Channel Blockers; Diltiazem; Dose-Response Relationship, Drug; Fatty Acids, Unsaturated; Hydrazines; In Vitro Techniques; Kidney Glomerulus; Male; Nifedipine; Prostaglandin Endoperoxides, Synthetic; Rats; Rats, Sprague-Dawley; Receptors, Thromboxane; Thromboxane A2; Vasoconstriction | 1997 |
Inhibitory effects of efonidipine hydrochloride on contraction induced by several vasoconstrictors in porcine coronary artery: comparison with effects of nifedipine and nisoldipine.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Binding, Competitive; Calcium Channel Blockers; Coronary Vessels; Dihydropyridines; Endothelin-1; In Vitro Techniques; Muscle Contraction; Muscle, Smooth, Vascular; Nifedipine; Nisoldipine; Nitrophenols; Organophosphorus Compounds; Potassium; Prostaglandin Endoperoxides, Synthetic; Serotonin; Swine; Thromboxane A2; Vasoconstrictor Agents | 1997 |
Endothelin-1-induced potentiation of adrenergic responses in the rabbit pulmonary artery: role of thromboxane A(2).
Topics: Animals; Antihypertensive Agents; Calcium Channel Blockers; Dose-Response Relationship, Drug; Electric Stimulation; Endothelin-1; Male; Nifedipine; Norepinephrine; Oligopeptides; Piperidines; Pulmonary Artery; Rabbits; Receptor, Endothelin B; Receptors, Endothelin; Thromboxane A2; Vasoconstriction; Vasoconstrictor Agents | 2001 |
Comparative effects of beraprost, a stable analogue of prostacyclin, with PGE(1), nitroglycerin and nifedipine on canine model of vasoconstrictive pulmonary hypertension.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Alprostadil; Animals; Antihypertensive Agents; Disease Models, Animal; Dogs; Dose-Response Relationship, Drug; Epoprostenol; Humans; Hypertension, Pulmonary; Male; Nifedipine; Nitroglycerin; Oxygen; Thromboxane A2; Vasoconstrictor Agents; Vasodilator Agents | 2001 |
U-46619-induced potentiation of noradrenergic constriction in the human saphenous vein: antagonism by thromboxane receptor blockade.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Aged; Calcium Channel Blockers; Dihydropyridines; Dose-Response Relationship, Drug; Drug Synergism; Electric Stimulation; Endothelium, Vascular; Female; Humans; In Vitro Techniques; Male; Middle Aged; Nifedipine; Norepinephrine; Potassium Chloride; Receptors, Thromboxane; Saphenous Vein; Stimulation, Chemical; Thromboxane A2; Vasoconstrictor Agents | 2001 |
Postnatal maturational shift from PKCzeta and voltage-gated K+ channels to RhoA/Rho kinase in pulmonary vasoconstriction.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; 4-Aminopyridine; Aging; Amides; Animals; Animals, Newborn; Calcium; Calcium Channel Blockers; Calcium Channels, L-Type; Endothelium, Vascular; In Vitro Techniques; Isoenzymes; Muscle Contraction; Muscle, Smooth, Vascular; Nifedipine; Patch-Clamp Techniques; Potassium Channels, Voltage-Gated; Protein Kinase C; Pulmonary Artery; Pyridines; rhoA GTP-Binding Protein; Signal Transduction; Swine; Thromboxane A2 | 2005 |
Thromboxane receptor stimulation suppresses guanylate cyclase-mediated relaxation of radial arteries.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Acetylcholine; Adrenergic alpha-Agonists; Calcium Channel Blockers; Colforsin; Coronary Artery Bypass; Epoprostenol; Guanylate Cyclase; Humans; Internal Mammary-Coronary Artery Anastomosis; Isometric Contraction; Mammary Arteries; Nifedipine; Nitric Oxide; Nitroglycerin; Norepinephrine; Organ Specificity; Phenylephrine; Potassium Chloride; Radial Artery; Receptors, Cytoplasmic and Nuclear; Receptors, Thromboxane; Soluble Guanylyl Cyclase; Thromboxane A2; Vascular Patency; Vasoconstriction; Vasoconstrictor Agents; Vasodilation; Vasodilator Agents | 2006 |
Renal microvascular actions of calcium antagonists.
Topics: Angiotensin II; Animals; Calcium; Calcium Channel Blockers; Kidney; Male; Microcirculation; Nifedipine; Norepinephrine; Prostaglandin Endoperoxides, Synthetic; Rats; Rats, Sprague-Dawley; Thromboxane A2; Vasoconstriction; Vasoconstrictor Agents | 1990 |
[Effect of Magnesium Sulfate, Nifedipine Tablet Combined Salvia Injection on ET-1/NO, TXA2/PGI2 and Hemorheology of Preeclampsia Patients].
Topics: Drug Therapy, Combination; Drugs, Chinese Herbal; Endothelin-1; Epoprostenol; Female; Hemorheology; Humans; Injections; Magnesium Sulfate; Nifedipine; Nitric Oxide; Pre-Eclampsia; Pregnancy; Salvia; Tablets; Thromboxane A2 | 2015 |